Bisamberg, Austria

Rudolf Hartmann



 

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 44(Granted Patents)


Location History:

  • Vienna, AT (2011)
  • Bisamberg, AT (2013 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Rudolf Hartmann: Innovator in Blood Coagulation Research

Introduction

Rudolf Hartmann is a notable inventor based in Bisamberg, Austria. He has made significant contributions to the field of blood coagulation through his innovative research and development of peptides that target the Tissue Factor Pathway Inhibitor (TFPI). With a total of 12 patents to his name, Hartmann's work has the potential to impact the treatment of blood coagulation disorders.

Latest Patents

Hartmann's latest patents focus on TFPI inhibitors and methods of use. These inventions provide peptides that bind to TFPI, including TFPI-inhibitory peptides and their compositions. The applications of these peptides are extensive; they may be used to inhibit TFPI, enhance thrombin formation in subjects with clotting factor deficiencies, increase blood clot formation, treat blood coagulation disorders, purify TFPI, and identify TFPI-binding compounds. The innovative nature of these patents highlights Hartmann's commitment to advancing medical science.

Career Highlights

Throughout his career, Rudolf Hartmann has worked with prominent companies in the biotechnology and pharmaceutical sectors, including Baxalta GmbH and Baxter International Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Hartmann's notable coworkers include Michael Dockal and Friedrich Scheiflinger. Their collaborative efforts have furthered the understanding and development of TFPI-related therapies.

Conclusion

Rudolf Hartmann's contributions to the field of blood coagulation through his innovative patents and collaborations with industry leaders underscore his importance as an inventor. His work continues to pave the way for advancements in medical treatments for blood coagulation disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…